250
Participants
Start Date
June 10, 2020
Primary Completion Date
May 19, 2021
Study Completion Date
May 19, 2021
Clobetasol propionate
Clobetasol propionate ophthalmic nanoemulsion 0.05%, is an oil-in-water (o/w), clear or slightly yellowish nanoemulsion containing the active ingredient clobetasol propionate at a concentration of 0.05% weight per weight (w/w)
Vehicle
Vehicle is identical in appearance and composition to clobetasol propionate ophthalmic nanoemulsion 0.05% but, without the active substance
Fifth Avenue Eye Associates, New York
Coastal Research Associates, Roswell
Eye Care Centers Management, Inc. (Clayton Eye Center), Morrow
Dixon Eye Care, Albany
Arus Research at Cape Coral Eye Center, Cape Coral
Apex Eye, Mason
Black Hills Regional Eye Institute, Rapid City
Chicago Cornea Consultants Ltd, Hoffman Estates
Chicago Eye Specialists, Chicago
Silverstein Eye Centers, Kansas City
Houston Eye Associates, Houston
Medical Center Ophthalmology Associates, San Antonio
Texan Eye, PA / Keystone Research Ltd., Austin
Arizona Eye Center, Chandler
Wellish Vision Institute, Las Vegas
Beverly Hills Institute of Ophthalmology, Beverly Hills
Wolston & Goldberg Eye Associates, Torrance
Pasedena Eye Medical Group, Pasadena
LoBue Laseer & Eye Medical Center, Murrieta
Santa Barbara Eyecare, Santa Barbara
Mark B. Kislinger, MD, Inc., Glendora
Martel Medical Eye Group, Rancho Cordova
Lead Sponsor
Salvat
INDUSTRY